Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Methylprednisolone stiffens aortas in lipopolysaccharide-induced chronic inflammation in rats.

Ko YH, Tsai MS, Lee PH, Liang JT, Chang KC.

PLoS One. 2013 Jul 17;8(7):e69636. doi: 10.1371/journal.pone.0069636. Print 2013.

2.

Aminoguanidine prevents fructose-induced arterial stiffening in Wistar rats: aortic impedance analysis.

Lin YT, Tseng YZ, Chang KC.

Exp Biol Med (Maywood). 2004 Nov;229(10):1038-45.

PMID:
15522840
3.

Effects of diabetes and gender on mechanical properties of the arterial system in rats: aortic impedance analysis.

Chang KC, Hsu KL, Tseng YZ.

Exp Biol Med (Maywood). 2003 Jan;228(1):70-8.

PMID:
12524476
4.

Pyridoxamine prevents age-related aortic stiffening and vascular resistance in association with reduced collagen glycation.

Wu ET, Liang JT, Wu MS, Chang KC.

Exp Gerontol. 2011 Jun;46(6):482-8. doi: 10.1016/j.exger.2011.02.001. Epub 2011 Feb 18.

PMID:
21316441
5.

Prevention of arterial stiffening by pyridoxamine in diabetes is associated with inhibition of the pathogenic glycation on aortic collagen.

Chang KC, Liang JT, Tsai PS, Wu MS, Hsu KL.

Br J Pharmacol. 2009 Aug;157(8):1419-26. doi: 10.1111/j.1476-5381.2009.00309.x.

6.

Aminoguanidine prevents age-related aortic stiffening in Fisher 344 rats: aortic impedance analysis.

Chang KC, Hsu KL, Peng YI, Lee FC, Tseng YZ.

Br J Pharmacol. 2003 Sep;140(1):107-14. Epub 2003 Jul 29.

7.

Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes.

Chang KC, Tseng CD, Wu MS, Liang JT, Tsai MS, Cho YL, Tseng YZ.

Eur J Clin Invest. 2006 Aug;36(8):528-35.

PMID:
16893374
8.

Effects of olmesartan on arterial stiffness in rats with chronic renal failure.

Chuang YC, Wu MS, Su YK, Fang KM.

Cardiovasc Diabetol. 2012 Jun 13;11:66. doi: 10.1186/1475-2840-11-66.

9.

Pharmacokinetic/pharmacodynamic modeling of methylprednisolone effects on iNOS mRNA expression and nitric oxide during LPS-induced inflammation in rats.

Sukumaran S, Lepist EI, DuBois DC, Almon RR, Jusko WJ.

Pharm Res. 2012 Aug;29(8):2060-9. doi: 10.1007/s11095-012-0733-5. Epub 2012 Mar 16.

10.

Zn2+ inhibits nitric oxide formation in response to lipopolysaccharides: implication in its anti-inflammatory activity.

Abou-Mohamed G, Papapetropoulos A, Catravas JD, Caldwell RW.

Eur J Pharmacol. 1998 Jan 12;341(2-3):265-72.

PMID:
9543248
11.

Aminoguanidine prevents arterial stiffening and cardiac hypertrophy in streptozotocin-induced diabetes in rats.

Chang KC, Hsu KL, Tseng CD, Lin YD, Cho YL, Tseng YZ.

Br J Pharmacol. 2006 Apr;147(8):944-50.

12.

Vascular effects of long-term propranolol administration after chronic nitric oxide blockade.

Priviero FB, Teixeira CE, Claudino MA, De Nucci G, Zanesco A, Antunes E.

Eur J Pharmacol. 2007 Oct 1;571(2-3):189-96. Epub 2007 Jun 13.

PMID:
17610863
13.

Methylprednisolone Protects Cardiac Pumping Mechanics from Deteriorating in Lipopolysaccharide-Treated Rats.

Ko YH, Tsai MS, Chang RW, Chang CY, Wang CH, Wu MS, Liang JT, Chang KC.

Front Physiol. 2015 Nov 26;6:348. doi: 10.3389/fphys.2015.00348. eCollection 2015.

14.

Activation of the PDK-1/Akt/eNOS pathway involved in aortic endothelial function differs between hyperinsulinemic and insulin-deficient diabetic rats.

Kobayashi T, Taguchi K, Nemoto S, Nogami T, Matsumoto T, Kamata K.

Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1767-75. doi: 10.1152/ajpheart.00536.2009. Epub 2009 Aug 28.

15.

autoregulatory role of endothelium-derived nitric oxide (NO) on Lipopolysaccharide-induced vascular inducible NO synthase expression and function.

Vo PA, Lad B, Tomlinson JA, Francis S, Ahluwalia A.

J Biol Chem. 2005 Feb 25;280(8):7236-43. Epub 2004 Dec 6.

16.

Ethanol suppresses L-arginine-induced relaxation response of rat aorta stimulated with bacterial lipopolysaccharide.

Hatake K, Wakabayashi I.

Nihon Arukoru Yakubutsu Igakkai Zasshi. 2000 Apr;35(2):61-8.

PMID:
10835879
17.

Failure of L-nitroarginine to inhibit the activity of aortic inducible nitric oxide synthase.

Darblade B, Batkai S, Caussé E, Gourdy P, Fouque MJ, Rami J, Arnal JF.

J Vasc Res. 2001 May-Jun;38(3):266-75.

PMID:
11399899
18.

Inhibition of glucocorticoid receptor binding by nitric oxide in endotoxemic rats.

Duma D, Silva-Santos JE, Assreuy J.

Crit Care Med. 2004 Nov;32(11):2304-10.

PMID:
15640646
19.

Chronic reduction of nitric oxide level in adult spontaneously hypertensive rats induces aortic stiffness similar to old spontaneously hypertensive rats.

Isabelle M, Simonet S, Ragonnet C, Sansilvestri-Morel P, Clavreul N, Vayssettes-Courchay C, Verbeuren TJ.

J Vasc Res. 2012;49(4):309-18. doi: 10.1159/000337470. Epub 2012 May 9.

PMID:
22572574
20.

Depression of cyclooxygenase-2 induction in aortas of rats with type 1 and type 2 diabetes mellitus.

Takahashi Y, Wakabayashi I.

Eur J Pharmacol. 2008 Oct 24;595(1-3):114-8. doi: 10.1016/j.ejphar.2008.07.047. Epub 2008 Jul 31.

PMID:
18706904
Items per page

Supplemental Content

Write to the Help Desk